Insider Buying: American Vanguard (NYSE:AVD) Director Acquires $39,710.00 in Stock

American Vanguard Corporation (NYSE:AVDGet Free Report) Director Steven Macicek purchased 19,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were purchased at an average cost of $2.09 per share, with a total value of $39,710.00. Following the completion of the acquisition, the director directly owned 99,711 shares in the company, valued at $208,395.99. The trade was a 23.54% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

American Vanguard Price Performance

NYSE:AVD opened at $2.23 on Friday. The firm has a market cap of $65.78 million, a PE ratio of -1.17 and a beta of 1.43. American Vanguard Corporation has a 12 month low of $2.03 and a 12 month high of $5.92. The company has a quick ratio of 1.40, a current ratio of 2.47 and a debt-to-equity ratio of 1.46. The company’s 50-day moving average price is $2.58 and its two-hundred day moving average price is $3.12.

American Vanguard (NYSE:AVDGet Free Report) last posted its quarterly earnings data on Monday, August 10th. The basic materials company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.43). American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.The firm had revenue of $116.75 million for the quarter, compared to analyst estimates of $135.00 million.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AVD. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Vanguard in a research report on Thursday, August 13th. Wall Street Zen cut American Vanguard from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

View Our Latest Research Report on AVD

Institutional Investors Weigh In On American Vanguard

Institutional investors and hedge funds have recently made changes to their positions in the company. R Squared Ltd acquired a new position in shares of American Vanguard during the first quarter valued at $28,000. Strs Ohio bought a new stake in American Vanguard during the 1st quarter worth about $28,000. nVerses Capital LLC bought a new stake in American Vanguard during the 4th quarter worth about $42,000. Virtu Financial LLC acquired a new position in American Vanguard during the 4th quarter valued at about $52,000. Finally, Jain Global LLC acquired a new position in American Vanguard during the 4th quarter valued at about $53,000. Institutional investors own 79.00% of the company’s stock.

About American Vanguard

(Get Free Report)

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

Recommended Stories

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.